Functional outcomes in schizophrenia.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Journal of Clinical Psychiatry

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Psychology

• Identifiers
  PMID 18533758
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Substance Misuse in Patients with Schizophrenia

  2012cited by this paper
• The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009.

  2010cited by this paper
• Family intervention for schizophrenia.

  2010cited by this paper
• Subjective life satisfaction and living situations of persons in Finland with long-term schizophrenia.

  2006cited by this paper
• Substance use and psychosocial functioning in schizophrenia among new enrollees in the NIMH CATIE study.

  2006cited by this paper
• Neuropsychological normalization with long-term atypical antipsychotic treatment: results of a six-month randomized, double-blind comparison of ziprasidone vs. olanzapine.

  2006cited by this paper
• Premorbid intra-individual variability in intellectual performance and risk for schizophrenia: a population-based study.

  2006cited by this paper
• The neurocognitive effects of aripiprazole: an open-label comparison with olanzapine

  2006cited by this paper
• Baseline Neurocognitive Deficits in the CATIE Schizophrenia Trial

  2006cited by this paper
• Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up.

  2005cited by this paper
• Cognitive rehabilitation for schizophrenia and the putative role of motivation and expectancies.

  2005cited by this paper
• A prospective 3-year longitudinal study of cognitive predictors of relapse in first-episode schizophrenic patients.

  2005cited by this paper
• Remission in schizophrenia: proposed criteria and rationale for consensus.

  2005cited by this paper
• The effectiveness of skills training for improving outcomes in supported employment.

  2005cited by this paper
• Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder

  2004cited by this paper
• The effect of family interventions on relapse and rehospitalization in schizophrenia--a meta-analysis.

  2004cited by this paper
• The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2003.

  2004cited by this paper
• Approaching a consensus cognitive battery for clinical trials in schizophrenia: the NIMH-MATRICS conference to select cognitive domains and test criteria.

  2004cited by this paper
• Does social cognition influence the relation between neurocognitive deficits and vocational functioning in schizophrenia?

  2004cited by this paper
• Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia.

  2003cited by this paper
• Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.

  2002cited by this paper
• Improving employment outcomes for persons with severe mental illnesses.

  2002cited by this paper
• Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder.

  2002cited by this paper
• The psychosocial treatment of schizophrenia: an update.

  2001cited by this paper
• Implementing supported employment as an evidence-based practice.

  2001cited by this paper
• Functional outcomes in schizophrenia: a comparison of olanzapine and haloperidol in a European sample

  2000cited by this paper
• Assertive community treatment for people with severe mental disorders.

  2000cited by this paper
• The effects of clozapine on alcohol and drug use disorders among patients with schizophrenia.

  2000cited by this paper
• Neurocognitive deficits and functional outcome in schizophrenia: are we measuring the "right stuff"?

  2000cited by this paper
• Cognitive functioning in schizophrenia: implications for psychiatric rehabilitation.

  1999cited by this paper
• Effects of cognitive treatment in psychiatric rehabilitation.

  1999cited by this paper
• Cost-effectiveness of intensive psychiatric community care for high users of inpatient services.

  1998cited by this paper
• Neurocognitive deficit in schizophrenia: a quantitative review of the evidence.

  1998cited by this paper
• Violence and severe mental illness: the effects of substance abuse and nonadherence to medication.

  1998cited by this paper
• Three-year trials of personal therapy among schizophrenic patients living with or independent of family, II: Effects on adjustment of patients.

  1997cited by this paper
• Family treatment, expressed emotion and relapse in recent onset schizophrenia.

  1997cited by this paper
• Lifetime co-occurrence of DSM-III-R alcohol abuse and dependence with other psychiatric disorders in the National Comorbidity Survey.

  1997cited by this paper
• Three-year trials of personal therapy among schizophrenic patients living with or independent of family, I: Description of study and effects on relapse rates.

  1997cited by this paper
• Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia.

  1996cited by this paper
• Substance use: a powerful predictor of relapse in schizophrenia.

  1996cited by this paper
• A comparison of two levels of family-aided assertive community treatment.

  1996cited by this paper
• Treatment, expressed emotion and relapse in recent onset schizophrenic disorders

  1996cited by this paper
• Predicting the "revolving door" phenomenon among patients with schizophrenic, schizoaffective, and affective disorders.

  1995cited by this paper
• Neuropsychological deficits in neuroleptic naive patients with first-episode schizophrenia.

  1994cited by this paper
• The comparative efficacy and long-term effect of clozapine treatment on neuropsychological test performance.

  1994cited by this paper
• Substance misuse in patients with schizophrenia

  year unknowncited by this paper

• Lumateperone for the Treatment of Adults With Schizophrenia: a Systematic Review

  2022cites this paper
• Increasing motivation in effort-based decision-making tasks: effects of salience and reward expectancy manipulations

  2021cites this paper
• Nonmedical Interventions for Schizophrenia

  2020cites this paper
• La reserva cognitiva en el trastorno mental grave

  2019cites this paper
• The association between antipsychotic and benzodiazepine use with brain morphology and its changes in schizophrenia

  2018cites this paper
• Recovery from Schizophrenia: An Autoethnography

  2018cites this paper
• Vocational Rehabilitation for Individuals with Schizophrenia: The Societal Case

  2017cites this paper
• Prediction of the intensity and diversity of day-to-day activities among people with schizophrenia using parameters obtained during acute hospitalization

  2017cites this paper
• Is it possible to achieve functional recovery in schizophrenia? A qualitative and quantitative analysis of psychiatrist´s opinion.

  2016influential citation
• Description of and Preliminary Findings for Occupational Connections, an Intervention for Inpatient Psychiatry Settings.

  2016cites this paper
• Factors discriminating employment status following in-patient evaluation among persons with schizophrenia

  2015cites this paper
• Discontinuing neuroleptic medication for psychosis : a systematic review of functional outcomes and a qualitative exploration of personal accounts

  2015cites this paper
• Comparison of self-report and performance-based measures of everyday functioning in individuals with schizophrenia: implications for measure selection

  2014cites this paper
• Functional recovery results from the risperidone long-acting injectable versus quetiapine relapse prevention trial (ConstaTRE)

  2013cites this paper
• medication management and patient choice Antipsychotic long-acting injections in clinical practice:

  2013cites this paper
• The beneficial effects of combining pharmacological and psychosocial treatment on remission and functional outcome in outpatients with schizophrenia.

  2013cites this paper
• Feasibility of pedometers for adults with schizophrenia: pilot study.

  2012cites this paper
• Validación de la versión española de la escala de Funcionamiento Personal y Social en pacientes ambulatorios con esquizofrenia estable o inestable

  2011influential citation
• Validation of the Spanish Personal and Social Performance scale (PSP) in outpatients with stable and unstable schizophrenia.

  2011cites this paper
• Effectiveness of integrated psychological therapy (IPT) for schizophrenia patients: a research update.

  2011cites this paper
• Executive control in chronic schizophrenia: A perspective from manual stimulus-response compatibility task performance.

  2011cites this paper
• Clinical Global Impression of Improvement (CGI-I) as a valid proxy measure for remission in schizophrenia: analyses of ziprasidone clinical study data.

  2011cites this paper
• The evolving concept of Treatment- Resistant Schizophrenia.

  2011cites this paper
• Emergency Department Psychiatric Assessment for Adults Discharged With a Principal Diagnosis of Schizophrenia in Maryland Community Hospitals With and Without inpatient Psychiatric Units

  2011cites this paper
• Fluid Intelligence and Psychosocial Outcome: From Logical Problem Solving to Social Adaptation

  2011cites this paper
• This material is the copyright of the original publisher. Unauthorised copying and distribution is prohibited. Progress in Defining Optimal Treatment Outcome in Schizophrenia

  2010cites this paper
• Testing definitions of symptom remission in first-episode psychosis for prediction of functional outcome at 2 years.

  2010cites this paper
• Klinisch-Neuropsychologische Aspekte der Therapie mit Psychopharmaka

  2010cites this paper
• Progress in Defining Optimal Treatment Outcome in Schizophrenia

  2010cites this paper
• The Relationship Between Symptoms and Stress in Adolescents with Schizophrenia

  2009cites this paper
• Antipsychotic Drug Treatment for Patients with Schizophrenia: Theoretical Background, Clinical Considerations and Patient Preferences

  2009cites this paper
• A COMPARISON OF THE DISCRIMINATIVE STIMULUS PROPERTIES OF THE ATYPICAL ANTIPSYCHOTIC CLOZAPINE AND THE GLUTAMATE AGONIST N-METHYL D-ASPARTATE IN C57BL/6 MICE.

  2009cites this paper
• Antipsychotic long-acting injections in clinical practice: Medication management and patient choice

  2009cites this paper
• EXAMINATION OF THE DISCRIMINATIVE STIMULUS AND CROSS-TOLERANCE INDUCING PROPERTIES OF N-DESMETHYLCLOZAPINE IN C57BL/6 MICE.

  2009cites this paper